explore -WSS

explore

author：leisure time 2025-09-29 15:04:39 - browse：18296

A medical insurance document printed with the words "COPAY," "DEDUCTIBLE," "COINSURANCE," "NON-COVERED," next to a pen — coverage from STAT — Adobe

WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending caps in most cases, after a Biden move in federal court on Tuesday.

Drug companies use copay coupons to help patients cover the cost of their drugs.

Before now, when drug companies helped patients pay their share of drug costs, insurers often didn’t count that assistance toward deductibles and out-of-pocket limits. In insurance jargon, this tactic is called a copay accumulator. Previously, the practice was only allowed when drug companies give coinsurance assistance for brand drugs with generic competition. The Trump administration let insurers use the tactic when cheaper generics were not available.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： At JPM 2024, hospital systems pitch financial strength to investors

WSS

A preacher's new calling: Diversifying neuroscience research

Medicare Advantage overpayments discussion gets experts fired up

Ascension's ugly legal battle over care for poor patients in Texas

Boston Scientific acquires urology company Axonics for $3.7 billion

Just how powerful is the placebo effect?

A preacher's new calling: Diversifying neuroscience research

focus

explore

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

HPV cancer vaccine study demonstrates efficacy

What does generative AI mean for health care? We asked experts

Ambulance rides for just $100? Advisers want major billing fixes

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare Advantage coverage denials need scrutiny, senators say

Drug repurposing or repositioning? The language matters

Boston Scientific acquires urology company Axonics for $3.7 billion

In age of alternative facts, a scholarly course on calling out crap

FDA approves Recor Medical high blood pressure device

hotspot

Diversify hospital leadership teams to protect BIPOC patient health

FDA approves potent Eli Lilly obesity drug, Zepbound

Medicare Advantage overpayments discussion gets experts fired up

HPV cancer vaccine study demonstrates efficacy

At JPM 2024, hospital systems pitch financial strength to investors

White House calls on federal agencies to crack down on AI abuses

leisure time

leisure time

entertainment

hotspot